AbbVie | ABBV - Dochód Netto

Cena Akcji
212.52
Dzienna Zmiana
0.93 0.44%
Miesięcznie
-6.38%
Rocznie
22.00%
Q2 Prognozy TE
202.55




Dochód Netto Zmiana Data
AbbVie USD 1.82B 1.63B 2025-12
Abbott USD 1.78B 132M 2025-12
ALKERMES USD 49.34M 33.42M 2025-12
Amgen USD 1.33B 1.88B 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Biogen USD 466.5M 168.3M 2025-09
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Coherus Biosciences USD -37.64M 2.11M 2025-12
Eisai JPY 17.18B 7.02B 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
J&J USD 5.12B 36M 2025-12
Medtronic USD 1.14B 231M 2025-12
Merck USD 2.96B 2.82B 2025-12
Neurocrine Biosciences USD 209.5M 102M 2025-09
Novartis USD 2.41B 1.52B 2025-12
Pacira USD 1.64M 3.8M 2025-12
Perrigo USD -1.42B 1.43B 2025-12
Pfizer USD -1.65B 5.19B 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR -801M 3.6B 2025-12
UCB EUR 1.08B 608M 2025-12
Ultragenyx Pharmaceutical USD -129M 51.41M 2025-12
United Therapeutics USD 364.3M 25.6M 2025-12
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12
Zoetis USD 603M 118M 2025-12